Association of k-ras, b-raf, and p53 status with the treatment effect of bevacizumab.
Ince WL; Jubb AM; Holden SN; Holmgren EB; Tobin P; Sridhar M; Hurwitz HI; Kabbinavar F; Novotny WF; Hillan KJ; Koeppen H; Journal Of The National Cancer Institute, 2005, vol. 97, issue 13, p 981, ISSN 14602105. ISBN 14602105.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef